Biomedical Intelligent Manufacturing: A New Engine for Industrial Upgrading and Development
2023-09-15
Author:
Number of views:

In recent years, with the rapid development of biomedical technology, the biomedical industry is facing new opportunities and challenges. On the one hand, consumers' health awareness continues to improve, and the demand for drugs and medical products is steadily increasing; on the other hand, the industrial policy environment is optimized, and the state vigorously promotes the technological transformation and industrial transformation of the biomedical industry. In this context, biomedical companies urgently need new technologies as a new engine for industrial upgrading to respond to market changes and challenges.
As a new generation of digital production technology, biomedical intelligent manufacturing has been proposed by the national "Biological Industry Development Plan (2021-2025)" and other policies, and has become an important direction for the transformation and upgrading of biomedical enterprises. Through the deep integration of advanced artificial intelligence, big data, automation technology and biomedical R & D and production process, it realizes the comprehensive reconstruction of enterprise management and business process, which is an important driving force for the industry to achieve high-quality development.
Biopharmaceutical intelligent manufacturing helps enterprises to comprehensively improve management and operational efficiency and meet market demand and regulatory requirements by deeply integrating advanced technology with the entire biopharmaceutical industry chain. It covers R & D design, manufacturing, supply chain management and other aspects to achieve industrial chain integration, reduce operating costs, improve product quality and R & D capacity, and strengthen the core competitiveness of enterprises.
Fuzhou Famo Youke Machinery Technology Co., Ltd. has technological leadership and innovation capabilities in the field of biomedical intelligent manufacturing.
In general, the company's solution has the characteristics of "three high:
Three: digital research and development, intelligent production, supply chain information. Reconstruct processes such as R & D, production and supply chain through digital technology to achieve efficient integration and collaboration of resources.
Two high: high throughput and high quality. In the R & D and design process, virtual test technology is used to accelerate the R & D of new drugs, realize the full digitization of the R & D process, and greatly improve the R & D efficiency and the speed of new drug launch. In the manufacturing stage, MES and automation equipment are used to monitor and optimize the production process to ensure high product quality and standardization, and significantly increase production capacity and output.
In the manufacturing process, the company's independent research and development of MES system and robot workstation, through the environmental data, equipment status and operating parameters for real-time monitoring, to achieve production process standardization and automatic optimization, to ensure high quality products. At the same time, the deep integration of artificial intelligence and the Internet is realized, and a self-learning and adaptive "smart factory" is built to achieve a substantial increase in production capacity and a significant reduction in costs.
In terms of supply chain management, through in-depth analysis of the market environment and resources, the company uses big data and forecasting models to optimize procurement and logistics solutions to achieve accurate management of the supply chain, minimize logistics links, reduce resource loss and improve resource efficiency.

Above: As a co-organizer, our company participated in the 5th Symposium on Research and Development, Filing and Market Transformation of Hospital Preparations in Medical Institutions and made a wonderful speech.
In the future, the company will continue to increase investment in technological innovation, broaden industry cooperation, continuously enrich the content of biomedical intelligent manufacturing solutions, help biomedical enterprises digital transformation, promote the integrated development of the industrial chain, achieve win-win and synergy, and make greater contributions to the development of the industry. The company will be committed to becoming the overall solution provider and partner trusted by customers, leading the development of the biomedical industry into a new era.
RELATED INFORMATION
